Form 4 for MANE Veradermics, Inc

Accepted 2026-02-05 00:00:00 ET · period of report 2026-02-03 · accession 0001628280-26-005910 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2026-02-05	2026-02-05	MANE	Grant-Kels Jane M.	Dir	C - Cnv Deriv	—	+2,455	2,455	New	—
D	2026-02-05	2026-02-05	MANE	Grant-Kels Jane M.	Dir	C - Cnv Deriv	—	-2,455	0	-100%	—
D	2026-02-05	2026-02-03	MANE	Grant-Kels Jane M.	Dir	A - Grant	$0.00	+51.5K	51.5K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2026-02-05	C	A	2,455	—	2,455	D	—	—	(F1) On February 5, 2026, the shares of Series A Convertible Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.00001 per share, on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date.
2	Derivative	Series A Convertible Preferred Stock	2026-02-05	C	D	2,455	—	0	D	— · — to —	2,455 Common Stock	(F1) On February 5, 2026, the shares of Series A Convertible Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.00001 per share, on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date.
3	Derivative	Stock Option (Right to Buy)	2026-02-03	A	A	51,525	$0.00	51,525	D	$17.00 · — to 2036-02-03	51,525 Common Stock	(F2) This option shall be fully vested and exercisable on February 3, 2027, the first anniversary of the vesting commencement date.